Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 12, 2007, Pages 1219-1222

  Keiser, Jennifer ^a   Utzinger, Jürg ^a   Vennerstrom, Jonathan L ^b   Dong, Yuxiang ^b   Brennan, Gerry ^c   Fairweather, Ian ^c  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Artemether; Fasciola hepatica; Oberon isolate; OZ78; Resistance; Triclabendazole

Indexed keywords

ANTIPLATYHELMINTIC AGENT; ARTEMETHER; OZ 78; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; WORM;

ADAMANTANE; ADMINISTRATION, ORAL; ANIMALS; ANTIPLATYHELMINTIC AGENTS; ARTEMISININS; BENZIMIDAZOLES; BILE DUCTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

ANIMALIA; FASCIOLA HEPATICA; RATTUS;

EID: 35748941249     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.07.012     Document Type: Article

References (23)

1. Alvarez-Sanchez M.A., Mainar-Jaime R.C., Perez-Garcia J., and Rojo-Vazquez F.A. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Vet. Rec. 159 (2006) 424-425
2. Behm C.A., and Sangster N.C. Pathology, pathophysiology and clinical aspects. In: Dalton J.P. (Ed). Fasciolosis (1999), CABI Publishing, Wallingford, UK 185-224
3. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Schellenbaum M., Von Orelli M., and Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 113 (1983) 315-317
4. Coles G.C. Treatment of fascioliasis in human infections. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 187
5. Eckstein-Ludwig U., Webb R.J., Van Goethem I.D., East J.M., Lee A.G., Kimura M., O'Neill P.M., Bray P.G., Ward S.A., and Krishna S. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 (2003) 957-961
6. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 79 (2005) 227-234
7. Fairweather I., and Boray J.C. Mechanism of fasciolide action and drug resistance in Fasciola hepatica. In: Dalton J.P. (Ed). Fasciolosis (1999), CABI Publishing, Wallingford, UK 225-276
8. Golenser J., Waknine J.H., Krugliak M., Hunt N.H., and Grau G.E. Current perspectives on the mechanism of action of artemisinins. Int. J. Parasitol. 36 (2006) 1427-1441
9. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., and Sachs J.D. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 3 (2006) e102
10. Ibarra F., Vera Y., Quiroz H., Canto J., Castillo R., Hernandez A., and Ochoa P. Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle. Vet. Parasitol. 120 (2004) 65-74
11. Keiser J., and Utzinger J. Emerging foodborne trematodiasis. Emerg. Inf. Dis. 11 (2005) 1507-1514
12. Keiser, J., Utzinger, J., in press. Current chemotherapy of food-borne trematodiasis and recent advances with artemisinins and synthetic trioxolanes. Trends Parasitol.
13. Keiser J., Engels D., Büscher G., and Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin. Invest. Drugs. 14 (2005) 1513-1526
14. Keiser J., Xiao S.H., Tanner M., and Utzinger J. Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J. Antimicrob. Chemother. 57 (2006) 1139-1145
15. Keiser J., Utzinger J., Tanner M., Dong Y., and Vennerstrom J.L. The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. J. Antimicrob. Chemother. 58 (2006) 1193-1197
16. McCoy M.A., McConville M., Brennan J.P., Kenny J.M., Edgar H.W.J., Ellison S., Flanagan A., Meaney M., Gordon A.W., Hanna R.E.B., and Fairweather I. The efficacy of the experimental flukicide, compound alpha against triclabendazole resistant Fasciola hepatica infections in sheep. 11th International Congress of Parasitology, Glasgow, Scotland 6-11 August 2006 (2006) abstract 1247
17. Schweizer G., Braun U., Deplazes P., and Torgerson P.R. Estimating the financial losses due to bovine fasciolosis in Switzerland. Vet. Rec. 157 (2005) 188-193
18. Turner K., Armour J., and Richards R.J. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep. Vet. Rec. 114 (1984) 41-42
19. Vera Montenegro Y., Ibarra Velarde F., Liebano Hernandez E., Quiroz Romero H., Castillo Bocanegra R., Hernandez Campos A., and Ochoa Galvan P. Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves. Parasitol. Res. 92 (2004) 211-214
20. Walker S.M., McKinstry B., Boray J.C., Brennan G.P., Trudgett A., Hoey E.M., Fletcher H., and Fairweather I. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitol. Res. 94 (2004) 427-438
21. Walker S.M., Hoey E., Fletcher H., Brennan G., Fairweather I., and Trudgett A. Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica. Parasitology 133 (2006) 209-216
22. WHO, 1995. Control of Foodborne Trematode Infections. Report of a WHO Study Group. World Health Organization, Geneva, Technical Report Series No. 849.
23. Xiao S.H., Chollet J., Utzinger J., Matile H., Mei J.Y., and Tanner M. Artemether administered together with haemin damages schistosomes in vitro. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 67-71